Innovation New Jersey
  • Home
  • Our Coalition
    • Contact Us
  • News
  • Resources
    • State Supports
    • Federal Supports
    • Higher Ed Supports
  • Join Us

Innovation News

Everything Innovation. Everything New Jersey.
Follow us and stay connected.

BioNJ Releases Its Recommendations to Governor-Elect Phil Murphy

1/6/2018

0 Comments

 
Trenton, NJ - BioNJ, the trade association for New Jersey’s life sciences industry, today released “The New Jersey Biopharma Industry: A Prescription for Growth,” a white paper that lays out how the biopharma sector can promote economic growth across New Jersey. The paper offers pragmatic recommendations for growing the industry in the Garden State and for strengthening New Jersey’s competitiveness.
“New Jersey has long been a critical economic engine for the United States, and the biopharmaceutical industry has been an important source of the State’s growth for generations,” said BioNJ President and CEO Debbie Hart. “As one of the top 10 innovation hubs in the world, New Jersey employs over 120,000 highly educated life sciences workers and is the operating base for over 1,000 biopharma companies, with more than 1,000 drugs in development by those companies. In fact, in 2015-2017 alone, New Jersey-headquartered biopharma companies accounted for 29% of the drugs approved by the FDA and extending that to companies with a footprint in New Jersey, the number jumps to nearly 50%.1
“However, the performance of the biopharma industry overall indicates New Jersey could be doing even better,” added Hart. “This report will serve as the basis for BioNJ’s recommendations to Governor-Elect Phil Murphy and to the New Jersey Biotechnology Task Force with the goal to create an environment that helps companies thrive and attracts new start-ups and funding to the Garden State. Developing an environment for growth is crucial for improving New Jersey’s economic health, and the State’s biopharma industry should be central to that strategy.”
The paper puts forth recommendations along four levers:
  • Direct government support of the industry, including making existing government programs easier to navigate.
  • Promotion of life sciences innovation and investment in the State, including creating and branding a potential “super cluster” of activity.
  • Educational and training programs, including linking existing pools of expertise (e.g., drug development and commercialization) to young companies.
  • Strengthening New Jersey’s brand, including increased promotion and marketing of the advantages of founding or moving a company to the State.
Click here to download The New Jersey Biopharma Industry: A Prescription for Growth.
Known as the “Medicine Chest of the World,” New Jersey has been a major global hub for biopharma for more than a century. Yet, as the report shows, in recent years, the State’s biopharma industry has not kept up with other states. The recommendations highlighted could bring jobs and more businesses that will help energize New Jersey’s economy.
“New Jersey’s life sciences industry has made great strides in recent years,” said Assemblyman Andrew Zwicker. “We have an opportunity to leverage this success and transform New Jersey into a biopharma hub that will be the envy of other states. BioNJ’s white paper, ‘The New Jersey Biopharma Industry: A Prescription for Growth’ offers us a road map to attracting and growing the companies that are revolutionizing medicine and technology.”
“We hope Governor-Elect Phil Murphy and the New Jersey Biotechnology Task Force find the white paper informative and will consider it as a call-to-action,” said Hart. “We look forward to working with the new Administration on these recommendations to grow the State’s economy and ensure that New Jersey continues to be the “Medicine Chest of the World — delivering valuable medical innovation for Patients around the globe.”
0 Comments



Leave a Reply.

    Do not miss a single innovative moment and sign up for our newsletter!
    Weekly updates


    Categories

    All
    3D Printing
    Academia
    Acquisitions
    Aerospace
    Agriculture
    AIDS
    Algae
    Alumni
    Animals
    Architecture
    Astrophysics
    Autism
    Awards
    Big Data
    Bioethics
    Biofuel
    Biomedical
    BioNJ
    Bioterrorism
    Bit Coins
    Brain Health
    Business
    Camden
    Cancer
    CCollege
    Cellular
    Centenary
    Chemistry
    ChooseNJ
    Climate Change
    Clinical Trials
    Cloud Tech
    Collaboration
    Computing
    Congress
    Coriell
    Council On Innovation
    Crowdfunding
    Cybersecurity
    DARPA
    Defense
    Degree
    Dementia
    Dental Health
    DOC
    DOD
    DOE
    Drew
    Drones
    Drug Creation
    Einstein's Alley
    Electricity
    Energy
    Engineering
    Entrepreneurship
    Environmental
    FAA
    Fairleigh Dickinson
    FDA
    Federal Budget
    Federal Government
    Federal Labs
    Federal Program
    Finance
    Food Science
    Fort Monmouth
    Fuel Cells
    Funding
    Genome
    Geography
    Geology
    Global Competition
    Google
    Governor Christie
    Grant
    Hackensack
    HackensackUMC
    Healthcare
    Health Care
    HHS
    HINJ
    Hospitals
    Immigration
    Incubator
    Infrastructure
    International
    Internet
    Investor
    IoT
    IP
    IT
    Jobs
    Johnson & Johnson
    K-12
    Kean
    Kessler
    Legislation
    Logistics
    Manufacturing
    Medical Devices
    Med School
    Mental Health
    Mentor
    Microorganisms
    Molecular Biology
    Montclair
    NAS
    Neuroscience
    Newark
    New Jersey
    NIFA
    NIH
    NIST
    NJBDA
    NJBIA
    NJ Chemistry Council
    NJCU
    NJDOLWD
    NJEDA
    NJEDge
    NJHF
    NJII
    NJIT
    NJMEP
    NJPAC
    NJPRO
    NJTC
    Nonprofit
    NSF
    OpEd
    Open Data
    OSHE
    OSTP
    Parasite
    Patents
    Paterson
    Patients
    Perth Amboy
    Pharma
    POTUS
    PPPL
    Princeton
    Prosthetics
    Ranking
    Rare Disease
    R&D Council
    Report
    Resiliency
    Rider
    Robotics
    Rowan
    Rutgers
    SBA
    Seton Hall
    Siemens
    Smart Car
    Smart Cities
    Software
    Solar
    Space
    SSTI
    Startup
    State Government
    STEM
    Stevens
    Stockton
    Subatomic
    Supports
    Sustainability
    Taxes
    TCNJ
    Teachers
    Telecom
    Therapy
    Thermodynamics
    Transportation
    Undergraduate
    USEDA
    Verizon
    Video Game
    Virtual Reality
    Water
    WHO
    William Paterson
    Women In STEM
    Workforce Development

Powered by Create your own unique website with customizable templates.